Amelioration of endothelial dysfunction by sodium glucose co‐transporter 2 inhibitors: pieces of the puzzle explaining their cardiovascular protection

Sodium glucose co‐transporter 2 inhibitors (SGLT‐2is) improve cardiovascular outcomes in both diabetic and non‐diabetic patients. Preclinical studies suggest that SGLT‐2is directly affect endothelial function in a glucose‐independent manner. The effects of SGLT‐2is include decreased oxidative stress...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Xiaoling, Preckel, Benedikt, Hermanides, Jeroen, Hollmann, Markus W., Zuurbier, Coert J., Weber, Nina C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Invited Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545205/
https://www.ncbi.nlm.nih.gov/pubmed/35393687
http://dx.doi.org/10.1111/bph.15850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545205/
https://www.ncbi.nlm.nih.gov/pubmed/35393687
http://dx.doi.org/10.1111/bph.15850

Ejemplares similares